KRISTOPHER ADAMS: Open Payments
NPI 1881036473 · GREENVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,421 in 83 payments from 20 companies in 2025. Trend: 2023 $926 · 2024 $1,197 · 2025 $1,421
Food & beverage: $1,383Education: $38
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 14 | $256 |
| Lilly USA, LLC | 13 | $216 |
| ABBVIE INC. | 16 | $201 |
| Axsome Therapeutics, Inc. | 8 | $188 |
| GlaxoSmithKline, LLC. | 4 | $71 |
| Novo Nordisk Inc | 4 | $63 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $53 |
| Esperion Therapeutics, Inc. | 3 | $50 |
| IBSA Pharma Inc. | 2 | $41 |
| Abbott Laboratories | 2 | $39 |
Products named: Auvelity, VRAYLAR, MOUNJARO, FARXIGA, AIRSUPRA, TRELEGY ELLIPTA, JARDIANCE, BREZTRI.
Industry payments across AL — which companies pay providers there.
